| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.26 | 5e-06 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 1e-05 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |